What does this video actually claim?
@chanelz.way shares her 6-month weight loss journey on Mounjaro (tirzepatide), showing steady progress through before and after photos. She mentions the medication "enhanced her life" and helped with her postpartum weight management.
The creator's honest about missing some weigh-ins during her journey. Her hashtags suggest she's dealing with postpartum depression and arthritis alongside weight management goals.
This is a personal testimony video, not medical advice. She's documenting her individual experience with tirzepatide for accountability purposes.
Does the science support her results?
Her timeline and apparent progress align well with clinical trial data for tirzepatide. The SURPASS-1 trial (Rosenstock et al., NEJM, 2021) showed average weight loss of 7.0-9.5% at 40 weeks depending on dose.
The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found even better results for weight management specifically. Participants lost 15.0% of body weight at 72 weeks on the 10mg dose, with 20.9% losing at least 20% of their starting weight.
Six months falls right in the sweet spot where tirzepatide users typically see substantial results. The medication works by activating both GLP-1 and GIP receptors, slowing gastric emptying and reducing appetite.
What's missing from her story?
She doesn't mention side effects, which is a pretty big omission. In SURMOUNT-1, 81.8% of participants experienced gastrointestinal adverse events, mostly nausea and diarrhea.
There's no discussion of the medication's cost, which runs about $1,000-$1,200 monthly without insurance coverage. That's not accessible for many people seeking similar results.
She also doesn't explain her dosing schedule or starting dose. Tirzepatide typically starts at 2.5mg weekly and titrates up to 5mg, 10mg, or 15mg based on tolerance and efficacy.
What should you know about Mounjaro for weight loss?
Tirzepatide isn't FDA-approved for weight management under the brand name Mounjaro. It's approved for type 2 diabetes. The weight loss formulation is called Zepbound, though it's the same active ingredient.
This matters for insurance coverage and prescribing practices. Many doctors prescribe Mounjaro off-label for weight loss, but your insurance might not cover it for that indication.
The medication requires ongoing use to maintain weight loss. In SURMOUNT-4 (Wadden et al., Nature Medicine, 2023), participants regained 14% of their body weight within 17 weeks of stopping treatment.
Results like @chanelz.way's are encouraging but individual. About 91% of people in SURMOUNT-1 lost at least 5% of their body weight, but responses varied widely.